*Paediatric Critical Care Medicine, Children's Hospital of Western Ontario, London Health Sciences Centre, London, ON, Canada;
†Department of Paediatrics, Schulich School of Medicine & Dentistry, Western University, London, ON, Canada;
‡Children's Health Research Institute, London, ON, Canada;
§Division of Paediatric Neurology, Department of Paediatrics, The Hospital for Sick Children, Toronto, ON, Canada; and
‖Department of Paediatrics, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
Address correspondence and reprint requests to Cecil D. Hahn, MD, MPH, Division of Paediatric Neurology, Department of Paediatrics, The Hospital for Sick Children, 555 University Ave, Toronto, ON M5G 1X8, Canada; e-mail: [email protected].
S. Lalgudi Ganesan holds a research grant from the Association of Medical Organizations of Southwestern Ontario (AMOSO) to study the nuances of implementation of a spectrogram-based seizure-screening program in Children's Hospital of Western Ontario. C. D. Hahn reports that he has served as a consultant on clinical trial design for Takeda Pharmaceuticals, UCB Pharma, and Greenwich Biosciences.
